Drugs / Nucleo CMP Forte
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT04499755 | Jun 2020 → Dec 2030 expected | brain injury | Tanta University | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Nucleo CMP Forte | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04499755 ↗ |